Matinas BioPharma Holdings, Inc.
MTNB- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001582554
No open-market purchases or sales by Matinas BioPharma Holdings, Inc. insiders were filed in the last 90 days; 25 institutions reported holding it in 13F filings for Q2 2026, worth $199.2K in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Matinas BioPharma Holdings, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 28
- +4 vs. Q2 2025
- Shares held
- 330.1K
- +53.7K (+19.4%) vs. Q2 2025
- Total value
- $617.7K
- +$363.6K (+143.1%) vs. Q2 2025
- New holders
- 5
- 8 more added
- Sold out
- 1
- 1 more reduced
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting MTNB on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 25 | $199.2K |
| Q1 2026 | 28 | $177.3K |
| Q4 2025 | 30 | $260.3K |
| Q3 2025 | 28 | $617.7K |
| Q2 2025 | 24 | $254.1K |
| Q1 2025 | 25 | $166.5K |
| Q4 2024 | 22 | $194.1K |
| Q3 2024 | 18 | $1.97M |
| Q2 2024 | 48 | $6.15M |
| Q1 2024 | 42 | $6.91M |
| Q4 2023 | 52 | $5.61M |
| Q3 2023 | 47 | $3.37M |
| Q2 2023 | 51 | $9.31M |
| Q1 2023 | 51 | $12.6M |
| Q4 2022 | 57 | $13.6M |
| Q3 2022 | 55 | $18.0M |
| Q2 2022 | 50 | $21.5M |
| Q1 2022 | 56 | $20.3M |
| Q4 2021 | 66 | $27.4M |
| Q3 2021 | 67 | $33.5M |
| Q2 2021 | 67 | $29.2M |
| Q1 2021 | 80 | $41.7M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Matinas BioPharma Holdings, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| MAI Capital Management | 2 | $4 | 0.00% | 00.0% | Unchanged |
| FMR LLC | 5 | $9 | 0.00% | +3+150.0% | Added |
| SBI Securities Co., Ltd. | 11 | $21 | 0.00% | 00.0% | Unchanged |
| Rothschild Investment LLC | 14 | $26 | 0.00% | 00.0% | Unchanged |
| Vision Financial Markets LLC | 40 | $76 | 0.00% | 00.0% | Unchanged |
| EverSource Wealth Advisors, LLC | 60 | $113 | 0.00% | 00.0% | Unchanged |
| Jones Financial Companies LLLP | 60 | $114 | 0.00% | 00.0% | Unchanged |
| Steward Partners Investment Advisory, LLC | 61 | $115 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 102 | $193 | 0.00% | 00.0% | Unchanged |
| Costello Asset Management, INC | 200 | $378 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 200 | $378 | 0.00% | +90+81.8% | Added |
| Advisor Group Holdings, Inc. | 210 | $394 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 422 | $798 | 0.00% | +417+8,340.0% | Added |
| Rockefeller Capital Management L.P. | 500 | $945 | 0.00% | +500 | New |
| Morgan Stanley | 561 | $1.06K | 0.00% | +417+289.6% | Added |
| Bank of America Corp | 979 | $1.85K | 0.00% | −3−0.3% | Reduced |
| Citigroup Inc | 1,260 | $2.38K | 0.00% | +1,260 | New |
| Tower Research Capital LLC (TRC) | 1,446 | $2.73K | 0.00% | +344+31.2% | Added |
| HRT Financial LP | 10,784 | $20.0K | 0.00% | +10,784 | New |
| Two Sigma Securities, LLC | 12,560 | $23.7K | 0.00% | +12,560 | New |
| State Street Corp | 15,322 | $29.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 22,594 | $42.7K | 0.00% | +22,594 | New |
| Renaissance Technologies LLC | 28,270 | $53.4K | 0.00% | +3,600+14.6% | Added |
| Holos Integrated Wealth LLC | 32,480 | $55.5K | 0.03% | 00.0% | Unchanged |
| Sargent Investment Group, LLC | 36,620 | $69.2K | 0.01% | +1,000+2.8% | Added |
| BlackRock, Inc. | 49,650 | $93.8K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 55,970 | $105.8K | 0.00% | +476+0.9% | Added |
| Vanguard Group Inc | 59,725 | $112.9K | 0.00% | 00.0% | Unchanged |
| Raymond James Financial Inc | 0 | $0 | 0.00% | −320−100.0% | Sold out |